LXR Biotech

LXR Biotech has 10 on-market SKUs in the DSLD, first entered 2013-03-25. 100.0% of its products declare at least one proprietary blend, and 0.0% of all its all-time SKUs are now off-market.

Report card

• Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 0.12
• % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 0.0%
• Average excipient count per product: 7.2
• First entry: 2013-03-25 · Latest entry: 2015-01-23
• Mineral/vitamin rows by quality tier: tier 1: 75%, tier 2: 12.5%, unrated: 12.5%

Products (10)